As of 2024-12-14, the EV/EBITDA ratio of Silk Road Medical Inc (SILK) is -20.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SILK's latest enterprise value is 1,170.43 mil USD. SILK's TTM EBITDA according to its financial statements is -57.03 mil USD. Dividing these 2 quantities gives us the above SILK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 12.3x | 10.1x |
| Forward P/E multiples | 8.9x - 11.3x | 10.3x |
| Fair Price | (13.84) - (17.12) | (15.63) |
| Upside | -150.3% - -162.3% | -156.9% |
| Date | EV/EBITDA |
| 2024-09-16 | -20.52 |
| 2024-09-13 | -20.53 |